| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts this week. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at leas... |
| 21 Oct 2026 |
8-K: Results of Operations and Financial Condition
Indianapolis, IN - October 21, 2026 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. |
| 10 Sep 2026 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts over the next several weeks. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year ... |
| 15 Jul 2026 |
8-K: Results of Operations and Financial Condition
Indianapolis, IN - July 15, 2026 - Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations. |
| 10 Jun 2026 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts this week. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at leas... |
| 13 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On May 13, 2026, Elevance Health, Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). There were 194,441,339 shares of common stock represented at the Annual Meeting, constituting a quorum. The shareholde... |
| 22 Apr 2026 |
8-K: Results of Operations and Financial Condition
Indianapolis, IN - April 22, 2026 - Elevance Health, Inc. (NYSE: ELV) reported first quarter 2026 results ahead of expectations. |
| 10 Mar 2026 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts over the next week. During these meetings, Company officers will reaffirm adjusted shareholders’ earnings for full year 2026 to be at least $25... |
| 02 Mar 2026 |
8-K: Other Events
On February 27, 2026, Elevance Health, Inc. (the “Company”) was notified by the Centers for Medicare & Medicaid Services (“CMS”) of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Comp... |
| 26 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization |
| 28 Jan 2026 |
8-K: Results of Operations and Financial Condition
Indianapolis, IN - January 28, 2026 - Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. |
| 10 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
INDIANAPOLIS – December 10, 2025 – The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, eff... |
| 10 Nov 2025 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors over the next week. During these meetings, Company officers expect to reaffirm the Company’s shareholders’ earnings guidance for full year 2025 to be approx... |
| 21 Oct 2025 |
8-K: Results of Operations and Financial Condition
Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively |
| 15 Sep 2025 |
8-K: Other Events
Elevance Health, Inc. (f/k/a Anthem, Inc.), an Indiana corporation (the “Company”), proposes to issue and sell to the several underwriters named in Exhibit A (the “Underwriters”), acting severally and not jointly, the respective principa... |
| 04 Sep 2025 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors over the next several weeks. During these meetings, Company officers expect to reaffirm the Company’s shareholders’ earnings guidance for full year 2025 to ... |
| 28 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
INDIANAPOLIS – July 28, 2025 – The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will also ... |
| 17 Jul 2025 |
8-K: Results of Operations and Financial Condition
Indianapolis, IN - July 17, 2025 - Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. |
| 28 May 2025 |
8-K: Regulation FD Disclosure
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors this week. During these meetings, Company officers expect to reaffirm the Company’s shareholders’ earnings guidance for full year 2025 to be $28.30 to $29.0... |
| 14 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On May 14, 2025, Elevance Health, Inc. (the "Company") held its Annual Meeting of Shareholders. The shareholders of the Company voted as follows on the matters set forth below. |
Loading...